showed that in 7735 men aged 40–59, serum albumin <40 g/L was associated with cancer mortality during a follow-up of 9 years, but confounding factors were not considered; equivocal data on serum albumin and cancer mortality were reported thereafter.8 This evidence concerns the gene ALB and cancer.